Clinical trial · Interventional
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
Research of Intensive Lifestyle Intervention for Overweight PCOS Patients With Impaired Glucose Tolerance in Their Metabolic and Reproductive Abnormalities Treatment
NCT02446834CI-TRIAL-00061488completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Compare the efficacy between intensive lifestyle intervention and drugs (GLP-1 Receptor Agonists, metformin and acarbose) for PCOS patients with early onset diabetes in their metabolic and reproductive abnormalities treatment; clear the treatment effect and mechanism of intensive lifestyle intervention to PCOS.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acarbose | Drug | — | UNRESOLVED |
| GLP-1 Receptor Agonists | Drug | — | UNRESOLVED |
| intensive lifestyle intervention | Behavioral | — | UNRESOLVED |
| Metformin | Drug | Metformin | ALIAS |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- intensive lifestyle intervention
- description
- 3 months intensive lifestyle intervention, including low GI diet and exercise.
- interventionNames
- Behavioral: intensive lifestyle intervention
- type
- EXPERIMENTAL
- label
- GLP-1 Receptor Agonists
- description
- 3 months GLP-1 Receptor Agonists treatment
- interventionNames
- Drug: GLP-1 Receptor Agonists
- type
- EXPERIMENTAL
- label
- metformin
- description
- 3 months metformin treatment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 14 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Overweight and obese PCOS patients with newly diagnosed IGT; PCOS diagnosis based on 1990 NIH criteria. Overweight / obesity diagnostic criteria according to WHO-WPR. IGT diagnostic criteria according to 1998 WHO diagnostic criteria. Exclusion Criteria: * Except for serious complications (cardiovascular events and recent significant kidney or lung disease within 3 months), and had high blood pressure (\>160/100mmHg), blood sugar and high blood lipids (glycated hemoglobin\> 11%, triglycerides \>600 mg/dl).
References
Publications (0)
Data not yet available
No reference posted for this study.